(Q45745904)
Statements
1 reference
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients (English)
1 reference
1 reference
Delgado J
1 reference
Pineda JA
1 reference
Corzo JE
1 reference
González-Moreno MP
1 reference
de la Rosa R
1 reference
Sánchez-Quijano A
1 reference
Leal M
1 reference
Lissen E
1 reference
1 November 1999
1 reference
61
1 reference
5
1 reference
766-769
1 reference
Identifiers
1 reference